AstraZeneca has deliberately chosen not to directly compete in the GLP-1/GIP receptor agonist space a strategic choice that, while differentiating, leaves it without exposure to the highest-growth peptide market segment (65.8% of the peptide therapy market
Citations Citations to this article as recorded by Efficacy Intravascular Lithotripsy Compared with Rotational/Orbital Atherectomy in Stent Restenosis: A Systematic Review Sidhi Laksono, Putri Nurbaeti, Ulfa Dwi Rahmawati Annals of Clinical Cardiology.2026
Ozempic (semaglutide) is one of the most in-demand medications for Type 2 diabetes on the market
As obesity rates rise in the U.S
State and federal governments jointly fund Medicaid, and the eligibility requirements vary by state
If you've struggled with exercise in the past, or if movement feels harder than it should, that's not a failure